Bodybuilding.com Hoists Its Regulatory Experience As Lesson For Compliance
This article was originally published in The Rose Sheet
Executive Summary
Highlighting dietary supplement sector's self-regulation at a recent supplement industry regulatory conference, the sports nutrition product marketer's chief counsel Bill Carter described his experience in federal court in 2012. He suggested some supplement firms, like Bodybuilding.com previously, don't consider themselves likely to incur litigation or criminal charges linked to regulatory problems when they learn about other businesses that have. "Just because you don't hear about a lot of FDA's office of Criminal Investigations doesn't mean they're not active," he said.
You may also be interested in...
US Supplement Market Growth: Is The Industry In Its Own Way?
Longtime supplement industry attorney Scott Bass says supplement manufacturers should work with FDA as an ally, including registering products with the agency pre-market, while FDA's second-in-command for supplement industry oversight, Robert Durkin, says the agency is not interested in preventing more safe products from reaching the market.
Steroids Sold As Supplements Targeted In FDA Actions, Congressional Hearing
Enhanced FDA enforcement against steroid products sold as dietary supplements is likely reassuring to law-abiding supplement companies
US FDA Supplement Facility Inspection Numbers Back To Typical Along With GMP Problems Found
Supplement facility GMP inspections by FDA in 2022 along with the frequency of form 483s sent to firms following inspections return to roughly pre-pandemic annual numbers after dipping during 2020 and 2021.